Have a personal or library account? Click to login
Phytotherapeutics oridonin and ponicidin show additive effects combined with irradiation in pancreatic cancer in vitro Cover

Phytotherapeutics oridonin and ponicidin show additive effects combined with irradiation in pancreatic cancer in vitro

Open Access
|Nov 2017

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29. 10.3322/caac.2125425559415
  2. Kleeff J, Friess H, Buchler MW. Neoadjuvant therapy for pancreatic cancer. Br J Surg 2007; 94: 261-2. 10.1002/bjs.573717315287
  3. Gillen S, Schuster T, Meyer Zum Buschenfelde C, Friess H, Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 2010; 7: e1000267. 10.1371/journal.pmed.100026720422030
  4. Naumann P, Habermehl D, Welzel T, Debus J, Combs SE. Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer. Strahlenther Onkol 2013; 189: 745-52. 10.1007/s00066-013-0393-323896631
  5. Han QB, Li ML, Li SH, Mou YK, Lin ZW, Sun HD. Ent-kaurane diterpenoids from Isodon rubescens var. lushanensis. Chem Pharm Bull (Tokyo) 2003; 51: 790-3.1284358310.1248/cpb.51.790
  6. Owona BA, Schluesener HJ. Molecular insight in the multifunctional effects of oridonin. Drugs R D 2015; 15: 233-44. 10.1007/s40268-015-0102-z26290464
  7. Tian W, Chen SY. Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin. Chin J Integr Med 2013; 19: 315-20. 10.1007/s11655-013-1437-323546635
  8. Bai N, He K, Zhou Z, Tsai ML, Zhang L, Quan Z, et al. Ent-kaurane diterpenoids from Rabdosia rubescens and their cytotoxic effects on human cancer cell lines. Planta Med 2010; 76: 140-5. 10.1055/s-0029-118600219653147
  9. Xu B, Shen W, Liu X, Zhang T, Ren J, Fan Y, et al. Oridonin inhibits BxPC-3 cell growth through cell apoptosis. Acta Biochim Biophys Sin (Shanghai) 2015; 47: 164-73. 10.1093/abbs/gmu13425651847
  10. Qi X, Zhang D, Xu X, Feng F, Ren G, Chu Q, et al. Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line. Int J Nanomedicine 2012; 7: 1793-804. 10.2147/IJN.S2948322619528
  11. Bu HQ, Liu DL, Wei WT, Chen L, Huang H, Li Y, et al. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Oncol Rep 2014; 31: 975-82. 10.3892/or.2013.288824297112
  12. Bu HQ, Luo J, Chen H, Zhang JH, Li HH, Guo HC, et al. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. Int J Oncol 2012; 41: 949-58. 10.3892/ijo.2012.151922710877
  13. Ikezoe T, Yang Y, Bandobashi K, Saito T, Takemoto S, Machida H, et al. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways. Mol Cancer Ther 2005; 4: 578-86. 10.1158/1535-7163.MCT-04-027715827331
  14. Liu JJ, Huang RW, Lin DJ, Peng J, Zhang M, Pan X, et al. Ponicidin, an entkaurane diterpenoid derived from a constituent of the herbal supplement PC-SPES, Rabdosia rubescens, induces apoptosis by activation of caspase-3 and mitochondrial events in lung cancer cells in vitro. Cancer Invest 2006; 24: 136-48. 10.1080/07357900500524371
  15. Liu JJ, Zhang Y, Guang WB, Yang HZ, Lin DJ, Xiao RZ. Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis. Int J Mol Sci 2008; 9: 2265-77. 10.3390/ijms911226519330074
  16. Zhang JF, Liu PQ, Chen GH, Lu MQ, Cai CJ, Yang Y, et al. Ponicidin inhibits cell growth on hepatocellular carcinoma cells by induction of apoptosis. Dig Liver Dis 2007; 39: 160-6. 10.1016/j.dld.2006.09.01117049940
  17. Liu YF, Lu YM, Qu GQ, Liu Y, Chen WX, Liao XH, et al. Ponicidin induces apoptosis via JAK2 and STAT3 signaling pathways in gastric carcinoma. Int J Mol Sci 2015; 16: 1576-89. 10.3390/ijms1601157625588213
  18. Murayama C, Nagao Y, Sano S, Ochiai M, Fuji K, Fujita E, et al. Effect of oridonin, a Rabdosia diterpenoid, on radiosensitization with misonidazole. Experientia 1987; 43: 1221-3.10.1007/BF019455333691743
  19. Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie J, et al. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood 2007; 109: 3441-50. 10.1182/blood-2006-06-032250
  20. Denekamp J, Waites T, Fowler JF. Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Biol 1997; 71: 681-94.924618310.1080/095530097143699
  21. Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979; 5: 85-91.10.1016/0360-3016(79)90044-0422420
  22. Morgan MA, Lawrence TS. Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways. Clin Cancer Res 2015; 21: 2898-904. 10.1158/1078-0432.CCR-13-322926133775
  23. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 2005; 337: 224-31. 10.1016/j.bbrc.2005.09.04016176802
  24. Roos WP, Kaina B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 2013; 332: 237-48. 10.1016/j.canlet.2012.01.00722261329
  25. MacPhail SH, Banath JP, Yu TY, Chu EH, Lambur H, Olive PL. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int J Radiat Biol 2003; 79: 351-8.1294324310.1080/0955300032000093128
  26. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 2002; 158: 486-92.1223681610.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2
  27. Zhang T, Tan Y, Zhao R, Liu Z. DNA damage induced by oridonin involves cell cycle arrest at G2/M phase in human MCF-7 cells. Contemp Oncol (Pozn) 2013; 17: 38-44. 10.5114/wo.2013.3377223788960
  28. Li YH, Wang X, Pan Y, Lee DH, Chowdhury D, Kimmelman AC. Inhibition of non-homologous end joining repair impairs pancreatic cancer growth and enhances radiation response. PLoS One 2012; 7: e39588. 10.1371/journal.pone.003958822724027
  29. Wang SQ, Wang C, Chang LM, Zhou KR, Wang JW, Ke Y, et al. Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway. Oncotarget 2016; 7: 72990-3002. 10.18632/oncotarget.1216627659528
  30. Cao S, Xia M, Mao Y, Zhang Q, Donkor PO, Qiu F, et al. Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway. Int J Oncol 2016; 49: 2075-87. 10.3892/ijo.2016.369627667173
DOI: https://doi.org/10.1515/raon-2017-0048 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 407 - 414
Submitted on: Jun 28, 2017
|
Accepted on: Oct 13, 2017
|
Published on: Nov 29, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Jakob Liermann, Patrick Naumann, Franco Fortunato, Thomas E. Schmid, Klaus-Josef Weber, Jürgen Debus, Stephanie E. Combs, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.